AOTI, INC. (the “Company” or “Group” or “AOTI”) AOTI Awarded Five Year Extension To Veterans Administration Contract AOTI, INC., a medical technology group focused on the durable healing of wounds and prevention of amputations, is...
AOTI, INC. (the “Company” or “Group” or “AOTI”) AOTI announces US FDA 510(k) Clearance of NEXA™ NPWT system for use in the home care setting Extension to Indications for Use follows submission of results from a human factors study evaluating the safe and effective use...
AOTI’s at-home TWO2® therapy is able to deliver oxygen topically into chronic wounds, including Diabetic Foot Ulcers (DFUs), and to encourage high-quality, durable wound healing OCEANSIDE, Calif., Dec. 4, 2023 /PRNewswire/ — AOTI Inc., the global leader in...
Dr. Mike Griffiths to lead discussions on durable wound healing at summit dedicated to advancing commercialization of cutting-edge wound care products OCEANSIDE, Calif., Nov. 27, 2023 /PRNewswire/ — AOTI Inc., the global leader in multimodality topical wound...
OCEANSIDE, Calif., July 14, 2023 /PRNewswire/ — AOTI Inc., the global leader in multimodality topical wound oxygen therapy, participated as a founding member of the Amputation Prevention Alliance (APA), in the “Preventing Diabetes-Related Amputations in...
OCEANSIDE, Calif., June 7, 2023 /PRNewswire/ — AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from ongoing WOCNext conference in Las Vegas, Nevada, where their game changing NEXA Negative Pressure Wound Therapy (NPWT)...
